Routine option grant with no immediate trading signal. Monitor for performance-based vesting conditions and any future updates on Lucid-MS or Unbuzzd royalty milestones.
Price Chart
Executive Summary
Quantum BioPharma granted 572,500 stock options to directors, officers, employees, and consultants at C$4.80 per share, with 172,500 vesting immediately and 400,000 subject to performance-based vesting. This is a routine equity incentive grant under the company's existing plan, with no material financial impact or change in business operations.
Key Facts
- 572,500 stock options granted at C$4.80 per share, expiring August 20, 2031
- 172,500 options vested immediately; 400,000 subject to performance-based vesting
- Options granted under omnibus equity incentive plan approved June 29, 2023
- Statutory four-month-and-one-day hold period applies
Financial Impact
No material financial impact disclosed; options are non-cash compensation
Risk Factors
- Dilution from option exercises if stock price exceeds C$4.80
- No disclosure of performance conditions for 400,000 options — uncertainty about vesting triggers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3349353 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 19d ago | 6-K | $3.11 | awaiting T+20 | — | $2.33 (−25.01%) |
Oct 6, 2026 21d ago | 6-K | $3.09 | awaiting T+20 | — | $2.33 (−24.53%) |
Oct 6, 2026 21d ago | Press Release | $3.09 | awaiting T+20 | — | $2.33 (−24.53%) |
Oct 5, 2026 22d ago | SC 13G/A | $3.27 | awaiting T+20 | — | $2.33 (−28.68%) |
Sep 24, 2026 4w ago | 6-K | $4.00 $2.27 | ▼ −43.25% | ▼ −42.83% | $2.33 (−41.70%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.33 (−37.31%) |
Sep 17, 2026 5w ago | 6-K | $3.72 $2.71 | ▼ −27.15% | ▼ −28.36% | $2.33 (−37.31%) |
Sep 15, 2026 6w ago | 6-K | $3.46 $2.89 | ▼ −16.47% | ▼ −19.45% | $2.33 (−32.60%) |
Sep 1, 2026 7w ago | 6-K | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.33 (−24.28%) |
Sep 1, 2026 7w ago | Press Release | $3.08 $3.60 | ▲ +16.88% | ▲ +17.21% | $2.33 (−24.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers